1. Home
  2. FTHM vs GRDX Comparison

FTHM vs GRDX Comparison

Compare FTHM & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

31.5M

Sector

Finance

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$5.21

Market Cap

28.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTHM
GRDX
Founded
2010
N/A
Country
United States
United Kingdom
Employees
N/A
2
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
28.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
FTHM
GRDX
Price
$0.58
$5.21
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
142.6K
132.4K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
32.71
N/A
EPS
N/A
N/A
Revenue
$420,477,000.00
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.45
N/A
52 Week Low
$0.48
$1.87
52 Week High
$3.37
$5.30

Technical Indicators

Market Signals
Indicator
FTHM
GRDX
Relative Strength Index (RSI) 31.31 77.98
Support Level $0.48 $2.08
Resistance Level $0.85 $5.30
Average True Range (ATR) 0.06 0.57
MACD -0.02 0.15
Stochastic Oscillator 20.91 90.38

Price Performance

Historical Comparison
FTHM
GRDX

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: